Potential problems surrounding the use of sublingually administered ophthalmic atropine for sialorrhea

Schizophr Res. 2017 Jul:185:202-203. doi: 10.1016/j.schres.2016.12.028. Epub 2016 Dec 30.

Authors

Jonathan G Leung¹, Kathryn M Schak²

Affiliations

¹ Department of Pharmacy, Mayo Clinic - Rochester, 1216 Second Street SW, Rochester, MN 55902, United States. Electronic address: [email protected].
² Department of Psychiatry and Psychology, Mayo Clinic - Rochester, 1216 Second Street SW, Rochester, MN 55902, United States.

PMID: 28043733
DOI: 10.1016/j.schres.2016.12.028

No abstract available

Keywords: Atropine; Clozapine; Ophthalmic; Sialorrhea.

Publication types

Case Reports
Letter

MeSH terms

Administration, Sublingual
Adult
Atropine / therapeutic use*
Humans
Male
Muscarinic Antagonists / therapeutic use*
Sialorrhea / drug therapy*

Substances

Muscarinic Antagonists
Atropine